Abstract: The disclosure described herein includes antifouling compositions, methods of antifouling by adhesion suppression and methods of selecting an antifouling composition which suppresses marine animal adhesion or reduces the strength of marine animal adhesion by reducing or quenching the oxidative adhesion chemistry of the marine animal.

Abstract: A method of controlling torque of a permanent magnet synchronous motor (PMSM) by using a speed-torque lookup table may include: receiving a current direct-current (DC) link voltage of an inverter configured to drive the PMSM and a speed of a rotor of the PMSM; calculating a change ratio of a DC link voltage based on the current DC link voltage and a DC link voltage at a time when the speed-torque lookup table is generated; calculating a normalized speed of the rotor according to a change in the DC link voltage by using the speed of the rotor and the change ratio of the DC link voltage; and/or transferring the normalized speed of the rotor as an input to the speed-torque lookup table.

Abstract: A DNA polymerase (Neq DNA polymerase) derived from Nanoarchaeum equitans is split into Neq L and Neq S fragments, each of which contains inteins. A Neq hot-start (HS) DNA polymerase in which the inteins of the Neq L and Neq S fragments are linked with each other is provided in the form of a precursor of Neq DNA polymerase. A purification method can be significantly improved by inserting a His-tag sequence composed of six histidine residues between the inteins of the Neq L and Neq S fragments at a gene level. As a result of effort to enhance PCR efficiency of the Neq HS DNA polymerase, a gene coding for the Neq HS DNA polymerase is mutated at specific positions to screen mutant Neq HS polymerases (M1, M2, and M3) having a highly improved PCR amplification rate and amplification level.

Abstract: Provided are methods for predicting the risk of pre-term birth in a pregnant subject, for identifying a subject having an increased risk of pre-term birth, for selecting a subject for participation in a clinical study, and for decreasing the risk of pre-term birth in a subject.

Abstract: The present invention provides a method for providing an image having visibility which is improved by removing fog or smoke from an image of which the quality is reduced due to the fog or the smoke. To this end, the present invention provides an estimation model used for obtaining, from an input image, an image from which the fog is removed, calculates a transmission rate indicating a ratio by which the fog is included in the original image by using the estimation model, and obtains an image of which the fog is removed using the calculated transmission rate. The method proposed in the present invention does not commonly use a filter and only uses calculation of a pixel unit, so that a back lighting effect is not generated, real time processing is possible due to a small amount of calculation, and a good image is obtained even by performing a process using only a luminance image.

Abstract: A synapse array based on a static random access memory (SRAM), a pulse shaper circuit, and a neuromorphic system are provided. The synapse array includes a plurality of synapse circuits. At least one synapse circuit among the plurality of synapse circuits includes at least one bias transistor and at least two cut-off transistors, and the at least one synapse circuit is configured to charge a membrane node of a neuron circuit connected with the at least one synapse circuit using a sub-threshold leakage current that passed through the at least one bias transistor.

Abstract: Butyrylcholinesterase (BChE) polypeptide variants of the presently-disclosed subject matter have enhanced catalytic efficiency for (?)-cocaine, as compared to wild-type BChE. Pharmaceutical compositions of the presently-disclosed subject matter include a BChE polypeptide variant having an enhanced catalytic efficiency for (?)-cocaine. A method of the presently-disclosed subject matter for treating a cocaine-induced condition includes administering to an individual an effective amount of a BChE polypeptide variant, as disclosed herein, to lower blood cocaine concentration.

Abstract: The invention provides methods for treating fibrosis, as well as methods for modulating mitochondrial peroxide production in a cell, and methods for modulating the import of Rac1 into the mitochondria of a cell.

Abstract: The present invention provides a method to ensure that distributed resources of a power distribution system remain connected to the circuitry of the power distribution system when a fault occurs at a distributed resource node to assist in identifying the location of the fault by continuing to inject current from the distributed resources into the distribution system, wherein at least one of the distributed resources is a wind turbine.

Abstract: A content adaptive compression system includes a plurality of encoders being coupled to receive a portion of an image, and accordingly generating candidate compressed codes, respectively, the plurality of encoders being configured for encoding images of different contents. An error count unit is configured to determine an amount of error between the image and the candidate compressed code for each of the encoders. A mode decision unit is coupled to receive a plurality of the amount of error, the candidate compressed code associated with least amount of error being outputted as an adaptive compressed code for the image.

Abstract: A clock and data recovery circuit is disclosed herein. The clock and data recovery circuit includes a phase detection unit, a charge pump, a loop filter, a voltage control oscillator, and a frequency detection unit. The voltage control oscillator has oscillation frequency that is variable in response to a frequency adjustment signal, and outputs an oscillation signal. The frequency detection unit includes a reference clock divider, a counter, and an oscillation frequency control unit. The reference clock divider generates a count-enable signal based on a reference clock signal. The counter generates an oscillation count signal by counting the pulses of the oscillation signal of the voltage control oscillator or the pulses of divided signals resulting from dividing the oscillation signal while the count-enable signal is being enabled. The oscillation frequency control unit compares a target count value with the value of the oscillation count signal, and outputs the frequency adjustment signal.

Abstract: The present disclosure relates to methods and compositions for modulating the activity of KCNQ channels as a means for reducing the effects of aberrant KCNQ channel function associated with epilepsy, deafness and arrhythmias including but not limited to, Long-QT syndrome (“LQTS”), and atrial fibrillation. The present disclosure also relates to the discovery of certain regions of KCNQ channels that interact with various channel stimulating molecules such as, ATP, and PIP2, as well as KCNQ channel domains that effect voltage dependant channel activation. The disclosure is also directed to the use of small molecules to modulate KCNQ channel activity in a cell. Moreover, the present disclosure relates to the therapeutic effects of treating a subject with modulators of KCNQ channel activity.

Abstract: Disclosed are high affinity antibodies or antigen binding fragments thereof, which bind an epitope that lies within the C terminal region of oncofetal antigen (OFA)/immature laminin receptor protein (iLRP), and which do not substantially cross-react with mature OFA/LRP. The antibodies may be conjugated to cytotoxic moieties to enhance their therapeutic efficacy. Methods of making the antibodies and therapeutic and diagnostic uses thereof are also disclosed.

Abstract: The present invention relates to an ?-helical cell-penetrating peptide multimer, a preparation method thereof and the use thereof, and more particularly, to a peptide multimer comprising a plurality of amphipathic peptides, a method for preparing the peptide multimer, a composition for preventing or treating HIV, which comprises the peptide multimer as an active ingredient, and a composition for intracellular delivery of a biologically active substance, which comprises the peptide multimer and the biologically active substance.

Abstract: A method of managing a cache includes storing first data of an upper level cache in a lower level cache, predicting a reuse distance level of second data having a same signature as the first data based on access information about the first data, and storing the second data in one of the lower level cache and a main memory based on the predicted reuse distance level of the second data.

Abstract: A phase converting device capable of use over a broad wavelength range, which may be used for optical beam transformations and combining, conversion of resonator and waveguide modes, correction of aberrations in optical systems, and selection of photons with specific phase profile. This provides significant advantages in high power laser systems. Large-mode-area fibers can be used to provide higher incident powers than can be achieved by single-mode fibers, reducing the number of elements in a system necessary to achieve the desired output. The profiles of these LMA fiber modes can then be converted from the undesired modes into the desired mode while combing their total power into a single beam.

Abstract: The present application relates generally to light emitting diodes and photodetectors as well as their methods of manufacture and use. In one exemplary embodiment, an integrated device may include a substrate, a light emitting diode formed on the substrate, and a photodetector formed on the substrate. In another embodiment, a device may include a light emitting diode formed on a substrate, and the light emitting diode may act as both a solid state light and as an optical transmitter.

Abstract: Disclosed herein are methods of treating a patient at risk of developing or having a neurofibromatosis or a sporadic schwannoma. In exemplary embodiments, the method involves administering to a subject in need an effective amount of a LIMK modulating agent. Also disclosed are compounds newly identified to be inhibitors of Merlin-null Schwann cell proliferation and/or survival.

Abstract: Polymer composite neutron detector materials are described. The composite materials include an aromatic polymer matrix, such as an aromatic polyester. Distributed within the polymer matrix are neutron capture agents, such as 6LiF nanoparticles, and organic or inorganic luminescent fluors. The composite materials can be formed into stretched or unstretched thin films, fibers or fiber mats.

Abstract: ‘UF08-5-10’ is a new coleus plant distinguished by having novel golden yellow, lance-shaped foliage with purple stems, and a well-branched growth habit, as disclosed herein.